On the afternoon of June 19, on the occasion of the 22nd CPHI World Pharmaceutical Raw Materials China Exhibition, the "CPHI China Innovative Drug Forum" sponsored by the China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products was successfully held in Shanghai.

In recent years, with the continuous release of various policies to encourage innovation and the improvement of enterprises' independent research and development capabilities, China's biopharmaceutical industry has achieved rapid development, and more and more Chinese innovative drug companies have gone overseas, playing an important role in the global innovative drug trade. With the continuous advancement of innovative drugs and international cooperation, China's pharmaceutical innovation has also become an indispensable part of the global pharmaceutical industry chain, and China's innovative drugs continue to benefit the world and move towards a broader world.

The theme of the "CPHI China Innovative Medicine Going to Sea Forum" held for the first time this year is "Innovation + going to sea dual-wheel drive, layout sustainable development", aiming to jointly discuss the status quo, opportunities and challenges of innovative medicine going to sea, gather the wisdom of the industry, in order to inject new impetus into the future development of the industry. The forum was presided over by Dr. Xia Mingde, Chairman of Inuo Lake Pharmaceutical (Hangzhou) Co., LTD. More than 100 representatives of pharmaceutical companies and institutions attended the forum.

Zhang Wei, President of the China Pharmaceutical Regulatory and Administration Society, said in his speech that the policy environment and internal and external conditions for the development of China's pharmaceutical industry have undergone profound changes in recent years, and it has entered a stage of high-quality development of accelerating innovation-driven, promoting the modernization of the industrial chain, and integrating into the global industrial system at a higher level.

At present, Chinese pharmaceutical enterprises go to sea boom, especially innovative drugs "go to sea", showing a good development trend, at the same time, the internationalization level of China's drug supervision is also constantly improving. The Chinese government has always attached great importance to international exchanges and cooperation in the field of drug regulation, constantly promoted supervision and international standards, and created a good international environment for the high-quality development of the industry. President Zhang Wei also said that he would further strengthen close cooperation with the Medical insurance Chamber of Commerce to actively help the international development process of China's innovative drugs.

Source: China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products